An expert review of voxelotor for the treatment of hemolytic anemia in patients with sickle cell disease: 'bridging the gap between laboratory data and patient related outcomes'.

Inusa, Baba P D; Mnika, Khuthala; Babiker, Samah

Inusa, Baba P D; Mnika, Khuthala; Babiker, Samah.

Afiliação

Inusa BPD; Paediatric Haematology, Evelina London Children's Hospital, Guy's and St Thomas NHS Foundation Trust, London.
Mnika K; Children and Women Academic Health Sciences, FOLSM, King's College London.
Babiker S; Division of Human Genetics, National Health Laboratory Service, and School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Expert Rev Hematol ; 16(8): 585-591, 2023.

Article em En | MEDLINE | ID: mdl-37329253

Assuntos

Anemia Falciforme; Hemólise; Humanos; Anemia Falciforme/complicações; Anemia Falciforme/tratamento farmacológico; Benzaldeídos/uso terapêutico; Pirazinas/uso terapêutico; Hemoglobinas; Hidroxiureia/uso terapêutico

Palavras-chave

GBT440; Sickle cell disease; anemia; hemolysis; vaso-occlusive crisis (VOC); voxelotor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemólise / Anemia Falciforme Tipo de estudo: Guideline / Observational_studies Limite: Humans Idioma: En Revista: Expert Rev Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google